Concentra Group Holdings Parent, Inc. (CON) — ESG & Values Scores

Environment story

Concentra discloses minimal environmental data. No Scope 1, 2, or 3 emissions disclosures are provided in the 10-K. No net-zero target or climate commitments are stated. The company acknowledges regulatory exposure to environmental compliance (facility licensing, waste handling) but does not report quantified environmental footprint, renewable energy usage, or decarbonization investments. Risk factors cite environmental matters in litigation context only. The lack of transparency on material emissions represents a significant gap for an occupational health company with 628+ facilities and 13,000+ employees. Deductions applied for missing Scope 3 disclosure (-15), absent net-zero target (-15), and no verified decarbonization infrastructure (+0). Environmental score capped at 60 due to near-complete absence of climate governance and emissions strategy.

Criticisms on file

Environmental compliance risk cited in Risk Factors relating to facility licensure, hazardous materials, and state environmental protection regulations; no evidence of material breaches or fines disclosed.
Source: CON 10-K Item 1A Risk Factors

Disclosed initiatives

No disclosed initiatives on file for this pillar.

Social story

Concentra reports a non-union workforce as of the filing date, but acknowledges significant union activity risk and labor shortage pressures. The 10-K states 'Although our workforce is currently non-union, we cannot predict the degree to which we will be affected by future union activity' and highlights labor shortages and increased turnover as material operational risks. No CEO-to-median-worker pay ratio is disclosed. No formal diversity metrics for executive or board leadership are provided in the filing. The company reports ~13,000 colleagues and affiliated physicians but provides no gender, racial, or ethnic composition data for workforce or leadership. No documented union-suppression activities are disclosed, though generic risk acknowledgment of union organizing is present. No supply-chain audits or human-rights commitments are disclosed. Social score reflects absence of union opposition activities (-0), but significant gaps in pay transparency, diversity disclosure, and labor-relations governance. Deductions: no CEO-to-median-worker ratio disclosure (-0 applied as unknown), no leadership diversity data (-15), no union-suppression litigation observed (-0).

Criticisms on file

Labor shortage and turnover risk acknowledged; company states 'An overall or prolonged labor shortage, lack of skilled labor, increased employee turnover or continued increase in the cost of recruiting and retaining employees could have a material adverse impact on our business.'
Source: CON 10-K Item 1A Risk Factors - Labor shortages section
Future union activity risk; company notes 'United States healthcare providers in recent years have seen an increase in the amount of union activity. Although our workforce is currently non-union, we cannot predict the degree to which we will be affected by future union activity.'
Source: CON 10-K Item 1A Risk Factors - Labor shortages section

Disclosed initiatives

Labor retention and recruitment programs

Company acknowledges need to enhance wages, benefits, and training to compete for qualified healthcare personnel and reduce turnover; specific metrics not disclosed.

Governance story

Concentra's governance structure is not fully disclosed in the 10-K excerpt provided. Board independence percentage, share class structure, and lobbying expenditures are not stated. The company discloses a single-class share structure (common stock) and operates under a credit agreement with standard covenants (leverage ratio cap of 6.5x, tested quarterly; leverage ratio as of Dec 31, 2025 was 3.4x). No evidence of dual-class supermajority founder voting or antitrust/consumer-fraud regulatory proceedings is mentioned. However, the company faces multiple litigation and regulatory investigation risks including DOJ and California Department of Insurance investigations into billing/coding for physical therapy claims, and PJ&A data-breach related lawsuits affecting ~4 million patients. These suggest governance challenges in compliance and risk management. Deductions applied: no board independence disclosure (-0 applied as unknown), no clear share structure governance (-0), active regulatory investigations (DOJ, state insurance dept) (-10 estimated for active investigations), healthcare compliance litigation and whistleblower exposure (-5 estimated). Governance score reflects lack of transparency and active compliance risks.

Criticisms on file

DOJ and California Department of Insurance investigations into billing and coding for physical therapy claims; investigations ongoing with potential for civil claims, consent decrees, or compliance agreements.
Source: CON 10-K Item 1A Risk Factors - Noncompliance with billing and documentation requirements; Item 3 Legal Proceedings
Perry Johnson & Associates (PJ&A) third-party vendor data breach notified Nov 10, 2023; notices sent to ~4 million patients in early Feb 2024; company subject to multiple lawsuits; potential enforcement actions, remediation costs, and loss of trust.
Source: CON 10-K Item 1A Risk Factors - Cybersecurity breach section; Item 3 Legal Proceedings
Multiple whistleblower and False Claims Act litigation exposures; company notes 'We, like other healthcare providers, are subject to investigations of the billing and coding of services provided to federal healthcare program, workers' compensation program, managed care and commercial insurance patients.'
Source: CON 10-K Item 1A Risk Factors - Litigation and investigations section
Corporate practice of medicine and fee-splitting legal risks in multiple states; company dependent on Management Service Agreements (MSAs) with physician-owned practices; risk of legal challenges to arrangements under state law.
Source: CON 10-K Item 1A Risk Factors - Corporate practice of medicine section

Disclosed initiatives

Compliance monitoring and audit programs

Company states 'we have policies and procedures in place' for regulatory compliance; monitors licensing, certification, and accreditation; conducts internal audits and payor audits. Specific governance bodies or board-level oversight structures not detailed.
Cybersecurity and data privacy programs

Company maintains cyber liability insurance and states reliance on 'training and security measures or other controls'; third-party vendor data breach (PJ&A) in Nov 2023 and Feb 2024 disclosures indicate vulnerabilities despite program claims.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Concentra Group Holdings Parent, Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Concentra Group Holdings Parent, Inc. in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)